Physician profile
Mark Sharobeem
NPI 1679915508
$1,677.15
in general payments reported to CMS, 2019-2025
11 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $203 · 2021: $203 · 2022: $200 · 2024: $193 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trilliant Surgical LLC. | $465.93 | 2019-2020 | |
| Stryker Corporation | $258.84 | 2021-2025 | Citrefix |
| Medline Industries Lp | $161.38 | 2019 | |
| Horizon Therapeutics Plc | $157.49 | 2019-2020 | |
| Linvatec Corporation | $153.33 | 2024 | Biobrace 23mm, Fracture and Correction Colag 2 |
| Acell, INC. | $124.32 | 2019 | |
| Kerecis Limited | $117.38 | 2022 | |
| Paragon 28, INC. | $116.40 | 2021 | |
| Treace Medical Concepts, INC. | $69.76 | 2022-2024 | |
| Dynasplint Systems INC. | $34.12 | 2022 | |
| Orthofix Medical, INC. | $18.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Sharobeem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.